Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

Imaging Tests Help Determine Cancer Treatment Success

Ivanhoe Broadcast News


(Ivanhoe Newswire) -- After receiving chemoradiotherapy treatment, there may now be a way to predict which head and neck cancer patients will respond to the treatment and who may need surgery.

Chemoradiotherapy is a combination of chemotherapy and radiation treatments, and has been used for the past two decades to help save organs while treating head and neck cancers. Following treatment, experts say it's important to assess the primary tumor site and cervical lymph nodes to look for any lingering disease, direct surgical salvage, and prevent recurrence.

Text Continues Below



Researchers at the Southern Illinois School of Medicine in Springfield analyzed 31 patients treated with chemoradiotherapy between 2004 and 2006. They all underwent positron emission tomography and computed tomography (PET-CT) six to eight weeks after they finished therapy, to look for persistent tumors. Overall, they found the PET-CT scans correctly predicted the response of the tumor 83 percent of the time. In patients whose cancer had spread to surrounding lymph nodes before they started treatment, the PET-CT scans correctly predicted the response of the tumor 75 percent of the time.

"On the basis of this study, PET-CT performed six to eight weeks after the completion of intra-arterial chemoradiotherapy for advanced squamous cell carcinoma of the head and neck is a valuable tool for measuring treatment response and facilitating clinical decision making," study authors wrote. "In addition to early prediction of treatment response, PET-CT provides early detection of distant metastases, which permits earlier intervention in patients with distant disease."

Source: Archives of OtolaryngologyHead & Neck Surgery, 2009;135(11):1119-1125



If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 11/19/2009

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake






About The HealthScout Network Contact Us
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service    
Advertising Policy

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.